These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38465197)

  • 1. iRGD-targeted Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Delivery.
    Barkovich KJ; Zhao Z; Steinmetz NF
    Small Sci; 2023 Aug; 3(8):. PubMed ID: 38465197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physalis Mottle Virus-Like Nanocarriers with Expanded Internal Loading Capacity.
    Barkovich KJ; Wu Z; Zhao Z; Simms A; Chang EY; Steinmetz NF
    Bioconjug Chem; 2023 Sep; 34(9):1585-1595. PubMed ID: 37615599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-Loaded Physalis Mottle Virus Particles Function as a pH-Responsive Prodrug Enabling Cancer Therapy.
    Hu H; Steinmetz NF
    Biotechnol J; 2020 Dec; 15(12):e2000077. PubMed ID: 32918857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Imaging.
    Hu H; Masarapu H; Gu Y; Zhang Y; Yu X; Steinmetz NF
    ACS Appl Mater Interfaces; 2019 May; 11(20):18213-18223. PubMed ID: 31074602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment.
    Zhong Y; Su T; Shi Q; Feng Y; Tao Z; Huang Q; Li L; Hu L; Li S; Tan H; Liu S; Yang H
    Int J Nanomedicine; 2019; 14():8543-8560. PubMed ID: 31802868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physalis Mottle Virus-Like Particles as Nanocarriers for Imaging Reagents and Drugs.
    Masarapu H; Patel BK; Chariou PL; Hu H; Gulati NM; Carpenter BL; Ghiladi RA; Shukla S; Steinmetz NF
    Biomacromolecules; 2017 Dec; 18(12):4141-4153. PubMed ID: 29144726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin Prodrug-Loaded Nanoparticles Based on Physalis Mottle Virus for Cancer Therapy.
    Hu H; Steinmetz NF
    Mol Pharm; 2020 Dec; 17(12):4629-4636. PubMed ID: 33186039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective Triple-Negative Breast Cancer Targeted Treatment Using iRGD-Modified RBC Membrane-Camouflaged Nanoparticles.
    Huang J; Lai W; Wang Q; Tang Q; Hu C; Zhou M; Wang F; Xie D; Zhang Q; Liu W; Zhang Z; Zhang R
    Int J Nanomedicine; 2021; 16():7497-7515. PubMed ID: 34803378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.
    Simón-Gracia L; Hunt H; Scodeller P; Gaitzsch J; Kotamraju VR; Sugahara KN; Tammik O; Ruoslahti E; Battaglia G; Teesalu T
    Biomaterials; 2016 Oct; 104():247-57. PubMed ID: 27472162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation.
    Hu C; Huang Y; Chen Y
    Mol Pharm; 2019 Feb; 16(2):561-572. PubMed ID: 30592418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Virus-Like Particle-Based Anti-HER2 Breast Cancer Vaccine.
    Hu H; Steinmetz NF
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34200802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory potential of iRGD peptide-conjugated garcinol-loaded biodegradable nanoparticles in rat colorectal carcinoma.
    Paul B; Gaonkar RH; Dutta D; Dasi R; Mukherjee B; Ganguly S; Das SK
    Biomater Adv; 2022 Mar; 134():112714. PubMed ID: 35581094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy.
    Chen J; Yang Q; Liu M; Lin M; Wang T; Zhang Z; Zhong X; Guo N; Lu Y; Xu J; Wang C; Han M; Wei Q
    Int J Nanomedicine; 2019; 14():8161-8177. PubMed ID: 31632025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells.
    Arduino I; Liu Z; Iacobazzi RM; Lopedota AA; Lopalco A; Cutrignelli A; Laquintana V; Porcelli L; Azzariti A; Franco M; Santos HA; Denora N
    Int J Pharm; 2021 Dec; 610():121246. PubMed ID: 34737115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy.
    Zhang J; Hu J; Chan HF; Skibba M; Liang G; Chen M
    Nanomedicine; 2016 Jul; 12(5):1303-11. PubMed ID: 26964482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iRGD mediated pH-responsive mesoporous silica enhances drug accumulation in tumors.
    Wang X; Zhao Y; Yan M; Liang X; Zhao N; Lu T
    Eur J Pharm Sci; 2024 Apr; 195():106725. PubMed ID: 38346565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthermia-triggered drug delivery from iRGD-modified temperature-sensitive liposomes enhances the anti-tumor efficacy using high intensity focused ultrasound.
    Deng Z; Xiao Y; Pan M; Li F; Duan W; Meng L; Liu X; Yan F; Zheng H
    J Control Release; 2016 Dec; 243():333-341. PubMed ID: 27984104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coadministration of iRGD with Multistage Responsive Nanoparticles Enhanced Tumor Targeting and Penetration Abilities for Breast Cancer Therapy.
    Hu C; Yang X; Liu R; Ruan S; Zhou Y; Xiao W; Yu W; Yang C; Gao H
    ACS Appl Mater Interfaces; 2018 Jul; 10(26):22571-22579. PubMed ID: 29878758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on "Coadministration of iRGD with Multistage Responsive Nanoparticles Enhanced Tumor Targeting and Penetration Abilities for Breast Cancer Therapy".
    Umeshappa CS; Shao K
    ACS Appl Mater Interfaces; 2018 Nov; 10(45):38659-38662. PubMed ID: 30360098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging-guided photothermal/photodynamic therapy against tumor by iRGD-modified indocyanine green nanoparticles.
    Yan F; Wu H; Liu H; Deng Z; Liu H; Duan W; Liu X; Zheng H
    J Control Release; 2016 Feb; 224():217-228. PubMed ID: 26739551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.